Skip to main content
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
32.39
+0.35 (1.09%)
May 9, 2025, 11:10 AM - Market open

Legend Biotech Revenue

In the year 2024, Legend Biotech had annual revenue of $627.24M with 119.97% growth. Legend Biotech had revenue of $186.52M in the quarter ending December 31, 2024, with 134.73% growth.

Revenue (ttm)
$627.24M
Revenue Growth
+119.97%
P/S Ratio
9.34
Revenue / Employee
$240,414
Employees
2,609
Market Cap
5.95B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024627.24M342.10M119.97%
Dec 31, 2023285.14M168.14M143.70%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M13.20M21.36%
Jan 1, 2020 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

LEGN News

More News